FCRL1 and lymphoma: Even though it is overexpressed by many different leukemias and lymphomas, there is little evidence for FCRL1 as a high-frequency target of recurrent mutation or genetic alteration in the catalogue of somatic mutations in cancer (COSMIC) database or other genomic analyses of lymphomas (25, 27, 123, 124).